In an exclusive interaction with Jayati Mukherjee, Mahidhwaj Sisodia talks about Cadila’s footprint, competitive position in global formulations market, global expansion strategy, changing consumer trend & its impact, cross border business & the associated legal implications, and many other aspects. Read the excerpts below.
“Cadila started with a simple vision to make affordable, quality medicine for the common man. This vision still drives all the decisions we take, this is the value that we bring. This was the vision of our founder chairman and we continue this. This vision has enabled us to establish our presence in more than 100 countries. Our international business has shown tremendous growth over the past two years and the journey for me has been really exciting.
Each country has a very different set of laws. We have been able to manage our presence across countries by having key people in the country who understand the regulations and plan ahead. Most of our international initiatives are planned at least a year ahead. This is of course done keeping in mind the laws of all the regions. Our dedicated medical, regulatory and legal teams also play a huge role in ensuring no regulations are overlooked by helping our teams in all policy related matters.”
Read the full interview here, on page no. 56: https://issuu.com/pharmabioworld/docs/pbw_december2019
